OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
40682056

BeautySkin Co Ltd

Personal ProductsVerified

BeautySkin Co Ltd's capital structure is characterized by a debt-to-equity ratio of 1.15, indicating a moderate reliance on debt financing. The company holds cash and equivalents of KRW 7,714,693,020, but this is insufficient to cover its long-term debt of KRW 37,120,856,190, resulting in a negative net cash position. The current ratio of 0.79 suggests liquidity constraints, as current assets fall short of current liabilities. Profitability metrics are weak, with a return on equity (ROE) of -5.37% and a return on assets (ROA) of -1.97%. These figures fall significantly below the industry median for ROE and ROA, which are typically positive for companies in the Personal Products sector. The company reported a net loss of KRW 1,727,890,660 and an operating loss of KRW 3,614,790,210, indicating operational inefficiencies and cost overruns. The company's revenue is concentrated in its domestic market, with limited disclosure on geographic diversification. No specific segment data is provided, but the company operates a single business line focused on cosmetic products. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes in South Korea. Growth prospects are muted, with no disclosed revenue growth in the most recent fiscal year. The company's operating cash flow of KRW 609,932,190 is insufficient to cover capital expenditures of KRW 249,047,140, resulting in a negative free cash flow of KRW 541,419,240. This suggests the company is not generating enough cash to sustain operations and investments without external financing. Risk factors include liquidity constraints and a high debt load, which could limit the company's ability to respond to market opportunities or downturns. The risk assessment indicates a medium liquidity risk and a low dilution risk, but the negative net cash position is a key flag. No recent dilutive events are disclosed, and the company has not issued new shares in the latest reporting period. Recent filings and transcripts do not provide additional insights into strategic initiatives or operational changes. The company's latest financial results highlight ongoing challenges in achieving profitability and managing debt, with no clear turnaround strategy disclosed in the available data.

30-day price · 406820+1602.00 (+86.2%)
Low$1763.00High$4550.00Close$3460.00As of21 May, 00:00 UTC
Profile
CompanyBeautySkin Co Ltd
Ticker406820.KQ
SectorConsumer Non-Cyclicals
BusinessPersonal & Household Products & Services
Industry groupPersonal & Household Products & Services
IndustryPersonal Products
AI analysis

Business. BeautySkin Co Ltd is a Korea-based company engaged in the manufacture and sale of cosmetic products, including skin care, mask packs, cleansing foam, and hand cream products, distributed domestically and internationally.

Classification. BeautySkin Co Ltd is classified under the Consumer Non-Cyclicals economic sector, Personal & Household Products & Services business sector, and Personal Products industry, with a confidence level of 0.92.

BeautySkin Co Ltd's capital structure is characterized by a debt-to-equity ratio of 1.15, indicating a moderate reliance on debt financing. The company holds cash and equivalents of KRW 7,714,693,020, but this is insufficient to cover its long-term debt of KRW 37,120,856,190, resulting in a negative net cash position. The current ratio of 0.79 suggests liquidity constraints, as current assets fall short of current liabilities. Profitability metrics are weak, with a return on equity (ROE) of -5.37% and a return on assets (ROA) of -1.97%. These figures fall significantly below the industry median for ROE and ROA, which are typically positive for companies in the Personal Products sector. The company reported a net loss of KRW 1,727,890,660 and an operating loss of KRW 3,614,790,210, indicating operational inefficiencies and cost overruns. The company's revenue is concentrated in its domestic market, with limited disclosure on geographic diversification. No specific segment data is provided, but the company operates a single business line focused on cosmetic products. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes in South Korea. Growth prospects are muted, with no disclosed revenue growth in the most recent fiscal year. The company's operating cash flow of KRW 609,932,190 is insufficient to cover capital expenditures of KRW 249,047,140, resulting in a negative free cash flow of KRW 541,419,240. This suggests the company is not generating enough cash to sustain operations and investments without external financing. Risk factors include liquidity constraints and a high debt load, which could limit the company's ability to respond to market opportunities or downturns. The risk assessment indicates a medium liquidity risk and a low dilution risk, but the negative net cash position is a key flag. No recent dilutive events are disclosed, and the company has not issued new shares in the latest reporting period. Recent filings and transcripts do not provide additional insights into strategic initiatives or operational changes. The company's latest financial results highlight ongoing challenges in achieving profitability and managing debt, with no clear turnaround strategy disclosed in the available data.
Key takeaways
  • BeautySkin Co Ltd is operating at a loss with a negative return on equity and assets, indicating poor profitability.
  • The company's liquidity position is weak, with a current ratio below 1 and a negative net cash position.
  • High debt levels and negative free cash flow suggest the company is not generating sufficient cash to sustain operations or reduce leverage.
  • The company's business is concentrated in a single product line and domestic market, increasing exposure to regional risks.
  • No recent strategic initiatives or turnaround plans are disclosed in the available data.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$54.92B
Gross profit$4.93B
Operating income-$3.61B
Net income-$1.73B
R&D
SG&A
D&A
SBC
Operating cash flow$609.9M
CapEx-$249.0M
Free cash flow-$541.4M
Total assets$87.68B
Total liabilities$55.49B
Total equity$32.19B
Cash & equivalents$7.71B
Long-term debt$37.12B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$54.92B-$3.61B-$1.73B-$541.4M
FY-1$80.87B-$3.45B-$5.06B-$4.58B
FY-2$80.90B-$8.41B-$8.64B-$7.17B
FY-3$58.94B$4.31B$3.36B$4.02B
FY-4$41.16B$3.22B$2.42B$2.97B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$87.68B$32.19B$7.71B
FY-1$82.99B$34.10B$13.15B
FY-2$74.24B$35.09B$3.05B
FY-3$64.48B$32.71B$7.67B
FY-4$67.61B$29.33B$6.56B
PeriodOCFCapExFCFSBC
FY0$609.9M-$249.0M-$541.4M
FY-1$8.89B-$656.5M-$4.58B
FY-2-$18.35B-$330.6M-$7.17B
FY-3$3.09B-$131.0M$4.02B
FY-4$3.74B-$67.0M$2.97B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$10.23B-$779.1M$2.13B$2.36B
FQ-1$11.45B$122.7M-$236.9M$139.6M
FQ-2$14.55B-$1.73B-$2.22B-$1.96B
FQ-3$18.70B-$777.1M-$1.41B-$1.09B
FQ-4$16.11B-$3.18B-$5.79B-$5.87B
FQ-5$18.19B-$1.28B-$1.32B-$1.01B
FQ-6$26.90B$1.82B$671.3M$1.23B
FQ-7$19.67B$1.42B$1.38B$1.07B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$87.68B$32.19B$7.71B
FQ-1$73.65B$28.59B$6.97B
FQ-2$75.10B$28.84B$7.83B
FQ-3$80.34B$31.07B$8.79B
FQ-4$82.99B$34.10B$13.15B
FQ-5$77.93B$35.81B$3.93B
FQ-6$82.02B$37.14B$4.34B
FQ-7$74.48B$36.47B$7.04B
PeriodOCFCapExFCFSBC
FQ0$609.9M-$249.0M$2.36B
FQ-1-$1.63B-$249.0M$139.6M
FQ-2$643.1M-$243.0M-$1.96B
FQ-3-$2.06B-$93.0M-$1.09B
FQ-4$8.89B-$656.5M-$5.87B
FQ-5$7.00B-$577.7M-$1.01B
FQ-6$6.45B-$508.7M$1.23B
FQ-7$6.79B-$659.1M$1.07B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$32.19B
Net cash-$29.41B
Current ratio0.8
Debt/Equity1.1
ROA-2.0%
ROE-5.4%
Cash conversion-35.0%
CapEx/Revenue-0.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Personal Products · cohort 225 companies
Metric406820Activity
Op margin-6.6%16.2% medp25 16.2% · p75 16.2%bottom quartile
Net margin-3.1%10.5% medp25 10.5% · p75 10.5%bottom quartile
Gross margin9.0%60.1% medp25 60.1% · p75 60.1%bottom quartile
R&D / revenue1.8% medp25 1.8% · p75 1.8%
CapEx / revenue-0.4%-2.3% medp25 -4.4% · p75 -1.1%top quartile
Debt / equity115.0%12724.1% medp25 12724.1% · p75 12724.1%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 05:16 UTC#4bc33854
Market quoteclose KRW 2885.00 · shares 0.01B diluted
no public URL
2026-05-04 02:10 UTC#d8637cce
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 05:17 UTCJob: f443c81e